Marcus Peck-Radosavljevic

Session 1: HCC: Origins, Detection & Treatment
(Sun 08:30 – 10:00 Rooms 5 & 6)
Presentation Title: Advances in Loco-regional treatment for HCC
(09:30 – 09:55)
click here to view session

Session 4: Advances in Cirrhosis Management
(Mon 16:00 – 17:30 Rooms 5 & 6)
Presentation Title: Novel  Targets for Portal Hypertension
(16:00 – 16:25)

click here to view session

Session 4: Controversies in Hepatology
(Tue 16:00 – 17:30 Rooms 5 & 6) Chairing Session

click here to view session

 


Professor Marcus Peck-Radosavljevic
MD MBA

Professor of Medicine and Chairman at the Department of Gastroenterology & Hepatology, Endocrinology and Nephrology at Klinikum Klagenfurt in Klagenfurt, Austria.

Professor Peck has served as Vice-secretary of EASL from 2011 to 2013 and as Secretary General of EASL from April 2013 to April 2015. He also served as the Secretary General of the Austrian Association for Internal Medicine from 2006-2014. He is member of the UEG Council since 2015 and the elected incoming Chair of the UEG Public Affairs Committee (PAC), which he will take over in 2018.

He began his research in liver disease in the field of portal hypertension and he is running a translational lab testing novel approaches to the treatment of portal hypertension and HCC. Later, he has been actively involved in the management of post-OLT hepatitis C and started running trials in HCV-infection in hemodialysis patients and HIV-HCV coinfection.

Over the last few years, Professor Peck has been leading the Portal Hypertension, the HIV-HCV-Coinfection, and the Hepatocellular Carcinoma (HCC) Study Groups at the Medical University of Vienna, Austria, where he has been conducting a number of clinical trials in these indications as well as on new antivirals in HCV-infection in special indications. Since January 2016, he has taken over as Chair of Internal Medicine and Gastroenterology & Hepatology in Klagenfurt.


Back to speakers